Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I results reported for analgesic CCR2 antagonist CNTX-6970

May 4, 2018

Abbisko presents novel candidates with promising preclinical profiles

May 4, 2018

Daiichi Sankyo profiles highlights of fourth quarter of fiscal 2017

May 4, 2018

Coherus BioSciences announces re-submission of BLA for CHS-1701

May 4, 2018

Azitra raises new financing to advance pipeline

May 4, 2018

Refuge Biotechnologies completes series B financing

May 4, 2018

FDA grants orphan drug designation to BN-Brachyury as treatment for chordoma

May 4, 2018

FDA advisory committee votes to recommend Siga's Tpoxx smallpox treatment

May 3, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...